Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
167
-
Total 13F shares, excl. options
-
20,523,914
-
Shares change
-
+233,419
-
Total reported value, excl. options
-
$3,376,925,666
-
Value change
-
+$44,308,851
-
Put/Call ratio
-
73%
-
Number of buys
-
90
-
Number of sells
-
-71
-
Price
-
$164.59
Significant Holders of INTERCEPT PHARMACEUTICALS IN - COM (ICPT) as of Q3 2016
225 filings reported holding ICPT - INTERCEPT PHARMACEUTICALS IN - COM as of Q3 2016.
INTERCEPT PHARMACEUTICALS IN - COM (ICPT) has 167 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20,523,914 shares
.
Largest 10 shareholders include FMR LLC (3,708,956 shares), AMERIPRISE FINANCIAL INC (2,626,000 shares), Capital World Investors (2,066,959 shares), Carmignac Gestion (2,015,192 shares), VANGUARD GROUP INC (1,179,083 shares), ORBIMED ADVISORS LLC (1,120,000 shares), JPMORGAN CHASE & CO (834,053 shares), STATE STREET CORP (625,016 shares), BlackRock Fund Advisors (493,670 shares), and BlackRock Institutional Trust Company, N.A. (437,337 shares).
This table shows the top 167 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.